![Text that says Results](/sites/default/files/styles/square_card_l/public/media/images/media-71.jpg.webp?itok=UNXuLIDJ)
No benefits from extra doses of rituximab in aggressive B-cell lymphoma
A recent clinical trial found that giving two additional doses of rituximab to people with aggressive B-cell lymphoma who responded to six cycles of R-CHOP did not improve outcomes.